Arterial Hypertension
Conditions
Keywords
Hypertension, ABPM
Brief summary
Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. There is evidence that ambulatory blood pressure monitoring (ABPM) results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. New international guidelines recognize the importance of ABPM which has an important and growing role in the diagnosis and in guiding antihypertensive therapy. In 2011 in the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommended that ABPM be performed on all patients with suspected hypertension to confirm the diagnosis and reduce unnecessary treatment in people who do not have true hypertension. The aim of this observational study is to describe the utility of ABPM generally and specifically in the management of hypertension by Cardiologists in the Algerian context.
Detailed description
The primary Objective of this study is to assess the benefit of the ABPM in the diagnosis and management of arterial hypertension in by Cardiologists. The Secondary Objectives are: * To identify the conditions of usage of ABPM for the diagnosis of arterial hypertension, * To evaluate the blood pressure during the ABPM assessment and at 6 weeks of follow up * To describe the study population (socio-demography), * To describe the therapeutic stratégies and the compliance to treatment.
Interventions
None listed
Sponsors
Axelys Sante Dz
Merinal Laboratoires
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who are either hypertensive (defined as those with a clinic SBP ≥ 140 mmHg or DBP ≥ 90 mmHg \[7\]) or referred for the assessment of hypertension * Informed consent obtained before any study-related activity
Exclusion criteria
* ABPM contraindication * Patient with psychiatric disorder * Patient not able to comply with study-related procedures based on clinical judgement of the investigator
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnosis of hypertension | At 24 hours after the inclusion in the study (Visit 2) | Valid 24h-ABPM: blood pressure ≥ 140/90 mmHg |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Demography | At the Inclusion in the study | Age, Sexe |
| Therapeutic Decison | At 24 hours after the inclusion in the study (Visit 2) | * Initiation of antihypertensive therapy in naive patients if the dianosis of hypertension is confirmed. * Maintain, switch or adaptation of treatment in treated patients. |
| Self-measurement of Arterial blood Pressure | At 6 weeks after the inclusion in the study (Visit 3) | Measurement of arterial pressure performed by the patient and reported on a follow up diary. Both systolic and diastolic pressures will be collected. |
| Evaluation of Compliance to treatment | At 6 weeks after the inclusion in the study (Visit 3) | Evaluation test based on the method developed by Xavier Girerd, consisting in 6 questions on the compliance. The rating is divised in three categories: Good compliant, moderate compliant or non compliant. according to Girerd et al. Evaluation de l'observance par l'interrogatoire au cours du suivi des hypertendus dans des consultations spécialisées - Arch Mal Cœur Vaiss. 2001 Aug. 94-(8):839-42. |
Countries
Algeria
Outcome results
None listed